Search the hub
Showing results for tags 'Medicine - Immunology'.
Found 9 results
-
Content ArticleThis review, published in Nature Reviews Immunology, looks at the research and data relating to long-Covid. Subsections include: Symptoms Possible mechanisms of long COVID Long-term disease risk following COVID-19 Therapeutics and outlook
-
Content Article
This blog is written in time for the WHO's World Immunisation Week. It explores vaccination programmes, in particular that for COVID-19 – it's uptake, both in the UK and globally, and the negative impact the pandemic has had on vaccination programmes for other diseases. -
Content ArticleThis article discusses how fibromyalgia is a poorly understood condition, and until now, was considered to originate in the brain, however, new research considers that the condition may actually be associated with the body's immune system. New findings published in the Journal of Clinical Investigation may help pave the way for more effective treatments for the millions of people affected by fibromyalgia.
-
Content ArticlePeople who have already been infected by some common cold viruses are less likely to get COVID, according to new results from a study by Kundu et al. funded by the NIHR.
-
Content ArticleDalila, who lives in Cardiff, was diagnosed with systemic lupus erythematosus during childhood. In this blog for Lupus Awareness Month she talks about her experiences with the condition and the differences in the care she’s received between England and Wales. The experience of people like Dalila is why the Rare Autoimmune Rheumatic Disease Alliance are calling for change in how people with rare autoimmune rheumatic diseases are cared for in Wales. They are calling for: A properly commissioned specialised centre for rare autoimmune rheumatic diseases in Wales. A network, where this specialised centre can support local hospitals to deliver better care. Urgent action to resolve workforce issues in rheumatology in Wales.
-
News Article
Covid: Gut bacteria may influence disease severity, study suggests
Patient Safety Learning posted a news article in News
A coronavirus patient's gut bacteria may influence the length and severity of their infection and their immune response to it, a new study suggests. A team of researchers at The Chinese University of Hong Kong examined whether the variety and quantity of microbiome played a role in COVID-19 infections. Researchers found that patients with COVID-19 were depleted in gut bacteria known to modify a person's immune response, and that this depletion appeared to persist 30 days after the virus had gone. Gut bacteria — or gut microbiome — help to digest food. But research increasingly shows that gut bacteria also affect our health. The study, published in the journal Gut, found that the composition of gut microbiome had changed in COVID-19 patients, compared to those who did not have the infection. It said that gut microbiome could be involved in the "magnitude of COVID-19 severity possibly via modulating host immune responses". Read full story Source: The Independent, 12 January 2021 -
Content ArticleA handful of immunologists are pushing the field to take attributes such as sex chromosomes, sex hormones, and reproductive tissues into account.
-
Content ArticleUK Biobank, commissioned by the Department for Health and Social Care, has produced its final round of results after testing over 20,000 people for coronavirus antibodies. The study is tracking the spread of the virus across England, Scotland and Wales over 6 months. The UK Biobank COVID-19 antibody study will analyse samples from people participating in its study to assess antibody levels over time. The data and insights from this study will help the government understand how long COVID-19 antibodies stay in the blood, how strong they are and what this could mean for potential immunity.
-
Content ArticleIn this opinion piece, authors highlight the growing cohort of patients who are suffering symptoms many months after their initial COVID-19 infection and the increasing demand on GP services. They also highlight a need for studies that can illuminate the underlying mechanism and for insights into the nature of this condition, how long it’s likely to go on for, what can be done about it, and through which clinical specialties. "Many estimates of long covid suggest that greater than 10% of acute cases have features that do not resolve over the subsequent months. Extrapolated to the current global burden of covid-19, this suggests potentially over five million current "long haulers"."
